3rd Circ. Won't Rethink Nixing $448M AbbVie Penalty

The full Third Circuit refused Friday to rethink a panel decision reversing a court-ordered $448 million penalty the Federal Trade Commission won against AbbVie and Besins for allegedly delaying generic forms...

Already a subscriber? Click here to view full article